Effective Use of ALK Inhibitors in EML4::ALK Positive Lymphatic Malformations
Beth Apsel Winger1,2, Christopher F. Dowd3, Kristin A. Shimano2, W. Patrick Devine4, Erin Mathes5, Ilona Frieden5, Carrie Schaefer6, Alok Kothari7
1Department of Clinical Pharmacy, UCSF, San Francisco CA
2Division of Pediatric Hematology, UCSF, San Francisco CA
3Division of Interventional Neuroradiology, UCSF, San Francisco CA
4Department of Anatomic Pathology, UCSF, San Francisco CA
5Department of Dermatology, UCSF, San Francisco CA
6Department of Radiology, Phoenix Children’s Hospital, Phoenix, AZ
7Division of Pediatric Hematology/Oncology, Phoenix Children’s Hospital, Phoenix, AZ